CovidVax show full list


Beijing Institute of BioProducts (Sinopharm) + Chinese Center for Disease Control and Prevention
vaccine type: Inactivated virus
Distribution updates
Aug 23China has authorised emergency usage of Beijing's inactivated vaccine to be used among people who are at high risk (by
Jul 23BeijingInstBio's vaccine could be ready for public use by the end of this year ahead of expectations (by
Apr 30BeijingInstBio's vaccine could be ready by end of 2020 being able to produce up to 100M doses (by
Human Testing updates (clinical trials)



started April 29 2020

with 6448 healthy people aged 3+

trial location: Shangqiu, China

» clinical trial details



started July 18 2020

with 15000 healthy people aged 18+

trial location: Abu Dhabi, UAE

» clinical trial details

PHASE 3 (Argentina)


started September 16 2020

with 3000 healthy volunteers aged 18-85

trial location: Buenos Aires, Argentina

» clinical trial details

Oct 15BeijingInstBio's vaccine was shown to be safe and triggered immune responses in either early or mid-stage test in humans (by
Sep 14UAE granted emergency approval for use of Beijing's inactivated vaccine (by
Aug 31Registration for the UAE's Beijing inactivated vaccine trials enrolled 31000 volunteers (by
Apr 30Beijing Institute of BioProducts received approval to start phase 1 clinical trials (by
Animal Testing updates (pre-clinical trials)
Jun 06BeijingInstBio's vaccine induces high levels of neutralizing antibodies titers in animal models (by
early development updates
currently no early development info

contact | about | ©2020 project